HealthySole Supplier in Charlotte, NC
Infection and Pathogen Transmission Control
Hospitals, surgery centers, and long-term care facilities are constantly improving IPC protocols to minimize risk of healthcare-acquired infections. In today’s COVID-19 care environment, those same facilities are searching for solutions to minimize the unintentional transmission of the virus throughout the healthcare facility. While they matter, improved handwashing and good PPE practice are not enough: shoes and floors are unaddressed yet known vectors for pathogen transmission.
How HealthySole Can Help
HealthySole PLUS is the first UVC-enabled shoe sole disinfection product to be independently clinically tested and also to have peer-reviewed published clinical research. HealthySole PLUS is proven to kill up to 99.99% of potential infection- and contamination-causing pathogens in just 8 seconds. And against the human coronavirus, HealthySole proved to be over 99.7% effective.
The Clinical Story
Clinical literature agrees that shoe soles carry the densest concentration of dangerous pathogens in the healthcare environment. Multiple published studies in IPC literature demonstrate that shoe soles are a vector for rapid migration and spread into and out of all sensitive locations within hospitals and other healthcare locations! These deadly pathogens, once introduced to an environment via shoe soles, transfer to floors where they are then rapidly transmitted to the air, elevated touch surfaces, and even patient/staff skin, through normal movement/aerosolization and horizontal transmission.
Infection and Contamination Focus Areas:
- OR and Surgical Recovery
- NICU/PICU/ICU(and especially ventilated patients)
- Sterile Processing (SPD)
- Infusion Cent
- Labor and Delivery
- Isolation/Contact Precaution
Independent Clinical Lab Test Results of Human Corona Virus 229E (ATCC VR-740) resulted in a deactivation rate of over 99.7% in three replicate tests.
University of Tennessee-Chattanooga College of Medicine/Erlanger Children’s Hospital
Poster presented at Tennessee Chapter American Academy of Pediatrics Fall 2019 Symposium (Best Poster Award). IRB-approved Clinical study: double-blinded 6-month study in the Pediatric Hematology/Oncology ward. Resulted in a significant -28% reduction of C difficile in positive swabs in rooms with HealthySole PLUS vs control rooms.
University of Houston/University of Texas School of Public Health
Published January 2018 in The Journal of Hospital Infection. Year long, 3-phase clinical study. Resulted in a 90+% reduction of pathogen presence (inoculated test organism: Enterococcus) on elevated furniture touch surfaces, patient bed, and patient skin in rooms tested when using HealthySole PLUS vs control/non-HealthySole PLUS room.